COMPARISON BETWEEN INCIDENCE AND RISK FACTORS IN ORAL CANCER IN DIFFERENT COUNTRIES IN LATIN AMERICA

Authors

  • Brenda Yuliana Herrera Serna Universidad Autónoma de Manizales. Universidad Autónoma del Estado de México
  • Edith Lara-Carrillo Universidad Autónoma del Estado de México
  • Victor Hugo Toral-Rizo Universidad Autónoma del Estado de México
  • Regiane Cristina do Amaral Universidade Federal de Sergipe

DOI:

https://doi.org/10.31052/1853.1180.v24.n2.24336

Keywords:

Cancer Oral, Fumar Tabaco, Consumo de Alcohol, Urbanizacíon, Estudio de Correlación

Abstract

The objectives were to describe incidence trends of oral cancer in Latin America according to sex between 2000-2017 and analyze its relationship with risk factors. Material and Method: Ecological study describing incidence trend of oral cancer in Latin America and correlation with smoking, drinking and urbanization. Results: Highest rates are seen in men (8.01) and women (3.64) from Cuba. There are general tendencies towards increase;
only Guatemala shows stagnation for both sexes. There is a positive relationship between the incidence of oral cancer and smoking. (r:0.37) and alcohol consumption (r:0.60) in men; and negative with the urbanization in both sexes (r:-0.16) (p:<0,01). Conclusion: The incidence varies among countries and within the countries according to sexes, with a
tendency to increase. The greatest load is on men in relation to risk factors.

Downloads

Download data is not yet available.

Author Biographies

Brenda Yuliana Herrera Serna, Universidad Autónoma de Manizales. Universidad Autónoma del Estado de México

Magister en Salud Pública. Estudiante de Posgrado en Universidad Autónoma del Estado de México (México). Investigadora en Universidad Autónoma de Manizales (Colombia).

Edith Lara-Carrillo, Universidad Autónoma del Estado de México

Doctora en Ciencias de la Salud. Directora Facultad de Odontología.

Victor Hugo Toral-Rizo, Universidad Autónoma del Estado de México

Doctor en Patología y Estomatología Oral. Coordinador de Posgrados de la Facultad de Odontología.

Regiane Cristina do Amaral, Universidade Federal de Sergipe

Doctora en Odontología Social. Profesora Adjuntadel Departamento de Odontologia. Universidade Federal de Sergipe.

References

Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.

Perdomo S, Roa G, Brennan P, Forman D, Sierra M. Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol. 2016;44S:S43-52.

de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP. Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck. 2010;35:357–67.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68(6):394–424.

Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde. Rio de Janeiro, Brasil; 2014.

Megwalu UC, Ma Y. Racial disparities in oropharyngeal cancer survival. Oral Oncol. 2017;65:33–7.

World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva, Switerland; 2018.

Leite I. Mortalidade por Câncer de Boca e Faringe em Cidade de Médio Porte na Região Sudeste do Brasil, 1980-2005. Rev Bras Cancerol. 2010;56(1):17–23.

Martinez VD, MacAulay CE, Guillaud M, Lam WL, Zhang L, Corbett KK, et al. Targeting of chemoprevention to high-risk potentially malignant oral lesions: Challenges and opportunities. Oral Oncol. 2014;50(12):1123–30.

Ferreira Antunes J, Toporcov T, Biazevic M, Boing A, Scully C, Petti S. Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case-control study. PLoS One. 2013;10(8):e68132.

Kim S. Human papilloma virus in oral cancer. J Korean Assoc Oral Maxillofac Surg. 2016;42(6):327–36.

Elango K, Suresh A, Erode E, Subhadradevi L, Ravindran H, Iyer S, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12(4):889–96.

Khangura R, Sengupta S, Sircar K, Sharma B, Singh S, Rastogi V. HPV involvement in OSCC: Correlation of PCR results with light microscopic features. J Oral Maxillofac Pathol. 2013;17(2):195–200.

Patil S, Rao R, Amrutha N, Sanketh D. Analysis of human papilloma virus in oral squamous cell carcinoma using p16: An immunohistochemical study. J Int Soc Prev Community Dent. 2014;4(1):61–6.

Blankart C. Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy (New York). 2012;105:128–37.

Chang T, Su Y, Lee C. Determinants for Aggressive End-of-Life Care for Oral Cancer Patients A Population-Based Study in an Asian Country. Medicine (Baltimore). 2015;94(4):e460.

Macedo da Silva, Bonfante Gisele Machado CJ, Alencar de Souza PE, Gurgel Andrade EI, de Assis Acurcio F, Cherchiglia Leal M. Specific 5-year oral cancer survival and associated factors in cancer outpatients in the Brazilian Unified National Health System. Cad Saúde Pública. 2014;30(5):983–97.

Goss P, Lee B, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St L, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013;14(5):391–436.

Mariotto A, Yabroff K, Shao Y, Al. E. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117–28.

Alforque Thomas A, Timmons A, Molcho M, Pearce A, Gallagher P, Butow P, et al. Quality of life in urban and rural settings: A study of head and neck cancer survivors. Oral Oncol. 2014;50(7):676–82.

Wagner K-H, Brath H. A global view on the development of non communicable diseases. Prev Med. 2012;54:S38–41.

Mao Y, Yang D, He J, Krasna MJ. Epidemiology of Lung Cancer. Surg Oncol Clin N Am. 2016;25:439–45.

Fei X, Chenc W, Zhang S, Liu Q, Zhang Z, Pei Q. The spatio-temporal distribution and risk factors of thyroid cancer during rapid urbanization–A case study in China. Sci Total Env. 2018;630:1436–45.

Attar E, Dey S, Hablas A, Seifeldin IA, Ramadan M, Rozek LS, et al. Head and neck cancer in a developing country: A population-based perspective across 8 years. Oral Oncol. 2010;46:591–6.

Angkurawaranon C, Jiraporncharoen W, Chenthanakij B, Doyle P, Nitsch D. Urbanization and non-communicable disease in Southeast Asia: a review of current evidence. Public Health. 2014;128:886–95.

Organización Panamericana de la Salud. Indicadores de salud: Aspectos conceptuales y operativos (Sección 2) [Internet]. Elaboración y medición de indicadores de salud. 2019 [cited 1BC Mar 30]. p. 1–6. Available from: https://www.paho.org/hq/index.php?option=com_content&view=article&id=14402:health-indicators-conceptual-and-operational-considerations-section-1&Itemid=0&lang=es

Washington U of. Institute of Health and Metrics Evaluation. Financing Global Health. 2018.

Institute for Health Metrics and Evaluation. Global Data Health Exchange. Global Burden of Disease (GBD). 2018. http://ghdx.healthdata.org

World Health Organization. Report on the global tobacco epidemic. Geneva; 2017.

World Bank. World Bank Open Data. Indicators. 2018. p. Gender. https://data.worldbank.org

World Health Organization, Pan American Health Organization. Informe sobre control del tabaco en la región de las Américas. Washington D.C.; 2016.

World Health Organization. Global status report on alcohol and health 2018. Switzerland; 2018.

Caribe IL y del, Sociales PE y. El uso de indicadores socioeconómicos en la formulación y evaluación de proyectos sociales. Santiago de Chile; 2001.

Antunes J, Waldman E. Trends and spatial distribution of deaths of children aged 12-60 months in São Paulo, Brazil, 1980-98. Bull World Heal Organ. 2002;80(5):391–8.

Estrada Perea LM, Peres MA, Boing AF, Ferreira Antunes JL. Trend of oral and pharyngeal cancer mortality in Brazil in the period of 2002 to 2013. Rev Saude Publica. 2018;52(10).

Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch F, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99.

de Sanjosé S, Diaz M, Castellsague X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence an genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–9.

Franceschi S, Castellsague X, Dal Maso L, Smith S, Plummer M, Ngelangel C, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer. 2002;86(5):705–11.

Kreimer A, Bhatia R, Messeguer A. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37(6):386–91.

Gillison M, Broutian T, Pickard R, Tong Z, Xiao W, L K, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693–703.

Ward E, Jemal A, Cokkinides V, Singh G, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2008;54(2):78–93.

Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–2150.

Chatenoud L, Bertuccio P, Bosetti C, Malvezzi M, Levi F, Negri E, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25:1843–53.

OCDE. OECD Health data: non-medical determinants of Health. OECD health statitics (database). 2014.

World Health Organization. WHO Global Report: mortality attributable to tobacco. Geneva; 2012.

Reynales-Shigematsu L, Fleischer N, Thrasher J, Zhang Y, Meza R, Cummings K, et al. Effects of tobacco control policies on smoking prevalence and tobacco-attributable deaths in Mexico: the SimSmoke model. Rev Panam Salud Publica. 2015;38:316–325.

Gilhodes J, Belot A, Bouvier A-M, Remontet L, Delafosse P, Ligier K, et al. Incidence of major smoking-related cancers: Trends among adults aged 20–44 in France from 1982 to 2012. Cancer Epidemiol. 2015;39:707–13.

Monteiro C, Cavalcante T, Moura E, Claro R, Szwarcwald C. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989–2003). Bull World Heal Organ. 2007;85:527–34.

Szklo A, de Almeida L, Figueiredo V, Autran M, Malta D, Caixeta R, et al. A snapshot of the striking decrease in cigarette smoking prevalence in Brazil between 1989 and 2008. Prev Med. 2012;54(2):162–7.

Abascal W, Esteves E, Goja B, Gonzalez M, Lorenzo A, Sica A, et al. Tobacco control campaign in Uruguay: a population-based trend analysis. Lancet. 2012;380(3):1575–82.

Hashibe M, Brennan P, Chuang sc Boscia S, Castellsague X, Chen C. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:541–50.

Andersson TM-L, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, et al. Avoidable cancers in the Nordic countriesdThe impact of alcohol consumption. Eur J Cancer. 2018;103:299e307.

Krüger M, Pabst A, Walter C, Sagheb K, Günther C, Blatta S, et al. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: A retrospective analysis of 88 patients and literature overview. J Craniomaxillofac Surg. 2018;42(7):1506–14.

Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin N Am. 2018;62:111–20.

Downloads

Published

2020-06-27

How to Cite

1.
Herrera Serna BY, Lara-Carrillo E, Toral-Rizo VH, do Amaral RC. COMPARISON BETWEEN INCIDENCE AND RISK FACTORS IN ORAL CANCER IN DIFFERENT COUNTRIES IN LATIN AMERICA. Rev. Salud Pública (Córdoba) [Internet]. 2020 Jun. 27 [cited 2024 Aug. 16];24(2):49-63. Available from: https://revistas.unc.edu.ar/index.php/RSD/article/view/24336

Issue

Vol. 24 No. 2 (2020): Revista de Salud Pública

Section

Scientific Articles

License

Copyright (c) 2020 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).